maria.vicario@vhir.org
VICARIO PEREZ, MARIA
iMarina ID: 04-25Grup
Fisiologia i Fisiopatologia Digestiva. Vall d'Hebron Institut de Recerca (VHIR). Passeig de la Vall d'Hebron. Barcelona. 08035
Grup
Malalties Digestives i Hepàtiques. Vall d'Hebron Institut de Recerca (VHIR). Passeig de la Vall d'Hebron. Barcelona. 08035
Codis d'identificació
Cronologia
desembre de 2004
Doctorat: Doctorado en Fisiología y Fisiopatología
Universitat de Barcelona
gener de 1998
Titulat superior / Grau: Grado en Farmacia
Universitat de Barcelona
gener de 1996
Titulat superior / Grau: Licenciado en Farmacia Orientación Sanitaria
Universidad Complutense de Madrid
Cronologia
gener de 2017
Investigadora senior- Estancia de investigación. Vall d'Hebron Institut de Recerca - Linkoping University
Vall d'Hebron Institut de Recerca - Linkoping University
2017 - 2017
gener de 2016
Investigador/a
Vall d'Hebron Institut de Recerca (VHIR). Fisiologia i Fisiopatologia Digestiva
2016 -
gener de 2016
Investigador/a
Vall d'Hebron Institut de Recerca (VHIR). Malalties Digestives i Hepàtiques
2016 -
setembre de 2014
Baixa de maternitat
Vall d'Hebron Hospital Institut de Recerca
2014 - 2015
gener de 2011
Investigador principal
Vall d'Hebron Institut de Recerca (VHIR). Malalties Digestives i Hepàtiques
2011 -
gener de 2011
Investigador Tenure Track (Contrato Miguel Servet I-CP10/00502). FUNDACIO INSTITUT DE RECERCA DE L'HOSPITAL UNIV. VALL D'HEBRON
FUNDACIO INSTITUT DE RECERCA DE L'HOSPITAL UNIV. VALL D'HEBRON
2011 - 2017
gener de 2010
Investigadora postdoctoral. FUNDACIO INSTITUT DE RECERCA DE L'HOSPITAL UNIV. VALL D'HEBRON
FUNDACIO INSTITUT DE RECERCA DE L'HOSPITAL UNIV. VALL D'HEBRON
2010 - 2011
gener de 2006
Investigadora postdoctoral. Cincinatti Children's Med Center -USA
Cincinatti Children's Med Center -USA
2006 - 2007
gener de 2006
Investigadora postdoctoral (FIS CD05/00060). FUNDACIO INSTITUT DE RECERCA DE L'HOSPITAL UNIV. VALL D'HEBRON
FUNDACIO INSTITUT DE RECERCA DE L'HOSPITAL UNIV. VALL D'HEBRON
2006 - 2009
octubre de 2005
Sénior
Vall d'Hebron Institut de Recerca (VHIR). Fisiologia i Fisiopatologia Digestiva
2005 -
octubre de 2005
Sénior
Vall d'Hebron Institut de Recerca (VHIR). Malalties Digestives i Hepàtiques
2005 -
gener de 2004
Investigadora asociada postdoctoral. FUNDACIO INSTITUT DE RECERCA DE L'HOSPITAL UNIV. VALL D'HEBRON
FUNDACIO INSTITUT DE RECERCA DE L'HOSPITAL UNIV. VALL D'HEBRON
2004 - 2005
gener de 2002
Investigadora predoctoral. McMaster University - Canada
McMaster University - Canada
2002 - 2002
gener de 2002
Profesora asociada. Universitat de Barcelona
Universitat de Barcelona
2002 - 2003
gener de 2000
Contrato investigadora predoctoral (Ministerio Educación). Universitat de Barcelona
Universitat de Barcelona
2000 - 2002
gener de 1999
Becaria predoctoral (Departamento de Fisiología). Universitat de Barcelona
Universitat de Barcelona
1999 - 2000
Reconeixements Investigació
Reconeixements Docents
Temàtiques més freqüents
Temáticas
Projectes participats
Direcció y participació en projectes
IP
NO IP
Grups, xarxes
Activitat docent
Centres
Hospital Universitario Vall d`Hebron
Master interuniversitario UB-UAB
Universitat Autònoma de Barcelona
Universidad de Barcelona
FUNDACIO INSTITUT DE RECERCA DE L'HOSPITAL UNIV. VALL D'HEBRON
Assignatura/Curs
Publicacions en Altmetrics
| 2018 | Activation of Eosinophils and Mast Cells in Functional Dyspepsia: An Ultrastruct... | |
| 2018 | Decreased TESK1-mediated cofilin 1 phosphorylation in the jejunum of IBS-D patie... | |
| 2018 | Toll-like receptors-mediated pathways activate inflammatory responses in the eso... | |
| 2018 | Activation of Eosinophils and Mast Cells in Functional Dyspepsia: an Ultrastruct... | |
| 2018 | Epithelial immunity: Priming defensive responses in the intestinal mucosa | |
| 2018 | Toll-like receptors-mediated pathways activate inflammatory responses in the eso... | |
| 2018 | Intestinal Barrier Function in Chronic Kidney Disease | |
| 2018 | A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies | |
| 2017 | Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of C... | |
| 2017 | miR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom p... | |
| 2017 | Abnormal barrier function in gastrointestinal disorders | |
| 2017 | miR-16 and miR-125b are involved in barrier function dysregulation through the m... | |
| 2017 | Mucosal pathobiology and molecular signature of epithelial barrier dysfunction i... | |
| 2017 | Randomised clinical trial: the analgesic properties of dietary supplementation w... | |
| 2017 | Downregulation of mucosal mast cell activation and immune response in diarrhoea-... | |
| 2016 | Mechanisms of Stress-Induced Visceral Pain: Implications in Irritable Bowel Synd... | |
| 2016 | The role of mast cells in functional GI disorders | |
| 2016 | The joint power of sex and stress to modulate brain-gut-microbiota axis and inte... | |
| 2016 | A weakly acidic solution containing deoxycholic acid induces esophageal epitheli... | |
| 2016 | Towards a new paradigm of microscopic colitis: Incomplete and variant forms | |
| 2016 | Dietary treatment modulates mast cell phenotype, density, and activity in adult ... | |
| 2015 | The intestinal barrier function and its involvement in digestive disease | |
| 2015 | Role of Corticotropin-releasing Factor in Gastrointestinal Permeability | |
| 2015 | Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bow... | |
| 2014 | Impaired duodenal mucosal integrity and low-grade inflammation in functional dys... | |
| 2014 | Comments on The Jejunum of Diarrhea-Predominant Irritable Bowel Syndrome Shows M... | |
| 2013 | Usefulness and limitations of sequential serum tryptase for the diagnosis of ana... | |
| 2013 | Diarrhoea-predominant irritable bowel syndrome: An organic disorder with structu... | |
| 2012 | Chronic psychosocial stress induces reversible mitochondrial damage and corticot... | |
| 2012 | The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alt... | |
| 2012 | Acute experimental stress evokes a differential gender-determined increase in hu... | |
| 2012 | Cellular and molecular basis of intestinal barrier dysfunction in the irritable ... | |
| 2011 | Eosinophils express muscarinic receptors and corticotropin-releasing factor to d... | |
| 2011 | Evaluation of oesophageal mucosa integrity by the intraluminal impedance techniq... | |
| 2010 | Chronological assessment of mast cell-mediated gut dysfunction and mucosal infla... | |
| 2010 | Role of microRNA in IBS with increased gut permeability | |
| 2010 | Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesop... | |
| 2009 | Impaired intestinal molecular tightness in the mucosa of irritable bowel syndrom... | |
| 2009 | Metabotyping of biofluids reveals stress-based differences in gut permeability i... | |
| 2008 | Maladaptive intestinal epithelial responses to life stress may predispose health... | |
| 2008 | Stress neuropeptides evoke epithelial responses via mast cell activation in the ... | |
| 2008 | Neuropharmacology of stress-induced mucosal inflammation: Implications for infla... | |
| 2007 | Stress-mast cell axis and regulation of gut mucosal inflammation: from intestina... | |
| 2007 | IL-13 involvement in eosinophilic esophagitis: Transcriptome analysis and revers... | |
| 2007 | Dietary glutamine affects mucosal functions in rats with mild DSS-induced coliti... | |
| 2007 | Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in ... | |
| 2006 | Targeting mast cells in the treatment of functional gastrointestinal disorders | |
| 2004 | Dietary plasma protein affects the immune response of weaned rats challenged wit... |
Col·laboracions institucionals darrers 5 anys
